C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Makes New Investment in Waters Co. (NYSE:WAT)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in Waters Co. (NYSE:WAT) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 8,469 shares of the medical instruments supplier’s stock, valued at approximately $2,909,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Barclays PLC boosted its stake in Waters by 34.8% in the third quarter. Barclays PLC now owns 159,995 shares of the medical instruments supplier’s stock worth $57,579,000 after purchasing an additional 41,339 shares in the last quarter. Savant Capital LLC lifted its stake in shares of Waters by 3.8% during the fourth quarter. Savant Capital LLC now owns 1,704 shares of the medical instruments supplier’s stock valued at $632,000 after acquiring an additional 63 shares during the period. Natixis Advisors LLC lifted its stake in shares of Waters by 71.9% during the third quarter. Natixis Advisors LLC now owns 140,992 shares of the medical instruments supplier’s stock valued at $50,742,000 after acquiring an additional 58,983 shares during the period. Public Sector Pension Investment Board lifted its stake in shares of Waters by 13.2% during the third quarter. Public Sector Pension Investment Board now owns 2,578 shares of the medical instruments supplier’s stock valued at $928,000 after acquiring an additional 300 shares during the period. Finally, Czech National Bank lifted its stake in shares of Waters by 6.5% during the fourth quarter. Czech National Bank now owns 12,874 shares of the medical instruments supplier’s stock valued at $4,776,000 after acquiring an additional 782 shares during the period. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Stock Down 2.5 %

Shares of Waters stock opened at $369.71 on Tuesday. Waters Co. has a 1 year low of $279.24 and a 1 year high of $423.56. The business has a 50-day moving average of $389.40 and a two-hundred day moving average of $364.87. The company has a market capitalization of $21.95 billion, a P/E ratio of 35.28, a price-to-earnings-growth ratio of 7.37 and a beta of 1.01. The company has a debt-to-equity ratio of 1.14, a current ratio of 2.02 and a quick ratio of 1.38.

Waters (NYSE:WAT) last announced its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.02 by $0.08. Waters had a return on equity of 49.93% and a net margin of 21.43%. As a group, equities analysts predict that Waters Co. will post 11.79 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on WAT. Barclays raised Waters from an “underweight” rating to an “equal weight” rating and upped their price target for the company from $360.00 to $415.00 in a research note on Monday, February 10th. Scotiabank raised Waters from a “sector perform” rating to a “sector outperform” rating and upped their price target for the company from $430.00 to $450.00 in a research note on Thursday, February 13th. TD Cowen upped their price target on Waters from $363.00 to $410.00 and gave the company a “hold” rating in a research note on Monday, November 4th. UBS Group increased their target price on Waters from $405.00 to $410.00 and gave the company a “neutral” rating in a research note on Thursday, February 13th. Finally, JPMorgan Chase & Co. increased their target price on Waters from $340.00 to $380.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. Ten research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $390.40.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.